跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,747 条关于
“reactive aldehyde species”
全部
10,747
临床试验
8,909
药物
188
机构
23
资讯
1,627
3年前
Reproxalap Shows Promise in Treating Dry Eye Disease by Targeting Ocular Inflammation
去年
FDA Sets New Review Date for Reproxalap in Dry Eye Disease
去年
FDA Accepts Aldeyra's Reproxalap NDA for Dry Eye Disease, AbbVie Option Expanded
2年前
Reproxalap Achieves Primary Endpoint in Phase 3 Dry Eye Disease Trial
去年
Aldeyra Therapeutics Resubmits NDA for Reproxalap for Dry Eye Disease Treatment
去年
FDA Accepts Aldeyra's Reproxalap NDA for Dry Eye Disease, Expands AbbVie Partnership
2年前
Aldeyra Therapeutics Plans Resubmission of Reproxalap NDA for Dry Eye Disease
9个月前
FDA Extends Review Timeline for Aldeyra's Reproxalap Dry Eye Treatment to March 2026
去年
FDA Accepts Aldeyra's Reproxalap NDA for Dry Eye Disease Treatment
去年
FDA Accepts Aldeyra's Reproxalap NDA for Dry Eye Disease with AbbVie Collaboration
第 1 页,共 163 页
上一页
下一页